Retention in Treatment after Emergency Department-Initiated Buprenorphine.
Retention in Treatment after Emergency Department-Initiated Buprenorphine.
复制标题
DOI：
10.1016/j.jemermed.2021.04.007
复制
发表时间：
2021-09
期刊：
影响因子：
--
通讯作者：
Brady KT
中科院分区：
文献类型：
--
作者：
Jennings LK;Lane S;McCauley J;Moreland A;Hartwell K;Haynes L;Barth KS;Gainey SS;Brady KT
急诊科启动的丁丙诺啡（EDIB）已被证明可有效地将阿片类药物使用障碍（OUD）患者与门诊治疗联系起来。五个不同的急诊科（ED）已经成功实施了EDIB计划。1)测量接受EDIB的患者首次转诊时的就诊率和30天治疗保留率; 2）描述接受EDIB的患者的人口统计学和阿片类药物使用特征; 3）确定5个参与ED的EDIB后的平均治疗时间。所有在参与ED接受EDIB的患者（n = 522）均由艾德的同行康复专家进行观察，并记录人口统计学和阿片类药物使用特征。对患者进行前瞻性随访。联系了转诊中心，并获得了关于首次转诊预约和30天治疗保留的信息。所有在30天时仍在接受治疗的患者在随后的30天间隔内持续随访，直至转诊中心指示患者已在其机构结束治疗。接受EDIB治疗的患者首次转诊就诊率为77.0%。在30天随访时，43.1%的患者继续接受治疗。患者入组的平均年龄为36.7岁，58%的入组者为男性，90.5%为白色，73.4%没有医疗保险。77%的人报告没有使用阿片类药物以外的药物。平均治疗时间为158天。EDIB计划在不同的艾德设置是有效的，以促进出席首次转诊预约OUD治疗;然而，额外的工作是必要的，以增加30天的治疗保留率，特别是在患者与非处方的唯一使用配置文件。
Emergency department-initiated buprenorphine (EDIB) has been shown to be effective in connecting patients with opioid use disorder (OUD) to outpatient treatment. Five diverse emergency departments (EDs) have successfully implemented EDIB programs. 1) To measure attendance at the first referral appointment and 30-day retention in treatment rates for patients receiving EDIB; 2) To describe demographic and opioid use characteristics of patients receiving EDIB; and 3) To determine average length of time in treatment after EDIB at the five participating EDs. All patients receiving EDIB at the participating EDs (n = 522) were seen by a peer recovery specialist in the ED and demographic and opioid use characteristics were recorded. Patients were followed prospectively. The referral site was contacted and information regarding attendance at the first referral appointment and 30-day retention in treatment was obtained. All patients still in treatment at 30 days were continually followed at subsequent 30-day intervals until the referral site indicated the patient had ended treatment at their facility. The rate of attendance at the first referral appointment was 77.0% for patients receiving EDIB. At 30-day follow-up, 43.1% of patients were retained in treatment. The mean age of patient enrollment was 36.7 years, 58% of enrollees were male, 90.5% were white, and 73.4% had no medical insurance. Seventy-seven percent reported no substance use other than opioids. The mean time in treatment was 158 days. EDIB programs across diverse ED settings are effective at promoting attendance at the first referral appointment for OUD treatment; however, additional work is warranted to increase 30-day treatment retention rates, particularly among patients with nonprescription-only use profiles.
登录
查看更多内容
影响因子：
2.8
作者：
Wesson, DR;Ling, W
通讯作者：
Ling, W
影响因子：
13.8
作者：
Schiff, Davida M.;Nielsen, Timothy;Taveras, Elsie M.
通讯作者：
Taveras, Elsie M.
在南部农村州实施由急诊部门启动的丁丙诺啡治疗阿片类药物使用障碍。
影响因子：
3.9
作者：
Bogan C;Jennings L;Haynes L;Barth K;Moreland A;Oros M;Goldsby S;Lane S;Funcell C;Brady K
通讯作者：
Brady K
药物和阿片类药物涉及过量死亡 - 美国，2017-2018。
DOI：
10.15585/mmwr.mm6911a4
发表时间：
2020-03-20
期刊：
MMWR. Morbidity and mortality weekly report
影响因子：
--
作者：
Wilson N;Kariisa M;Seth P;Smith H 4th;Davis NL
通讯作者：
Davis NL
影响因子：
3.9
作者：
Moreland, Angela;McCauley, Jenna;Brady, Kathleen
通讯作者：
Brady, Kathleen